Translate this website into the following languages:

Close Tab
UC San Diego Health
menu iconMenu
search iconSearch

Liver Cancer Care

The liver cancer experts at UC San Diego Health are fighting primary malignancies and metastases in new and aggressive ways. Our multidisciplinary team is committed to providing the highest level of care and includes specialists from hepatology, surgical oncology, medical oncology and interventional radiology. 

Cancers and benign tumors are accurately identified, staged and monitored by our advanced endoscopy unit and diagnostics team in gastroenterology.

Our Areas of Expertise

Diagnosis and Imaging

UC San Diego Health is home to a unique liver imaging group that includes radiologists, physicists, computer scientists, and biostatisticians. The group has developed sophisticated non-invasive techniques to diagnose pre-cancerous liver conditions and small tumors that were previously not detectable. These techniques — which include double-contrast magnetic resonance imaging (MRI) — can also be used to gather important information about a tumor, including its exact size, density, and how well it may respond to treatment.

Surgical Treatment

Hepatobiliary surgery is led by Alan Hemming, MD, a world recognized specialist in complex surgeries of the liver, pancreas and bile ducts including:

Chemotherapy and Radiotherapy

Specialists perform radiotherapy and administer advanced chemotherapies including:
  • Stereotactic body radiation therapy (SBRT)
    SBRT is a special form of external beam radiation that delivers ablative doses of radiation using beams precisely matched to the three dimensional shape of the tumor. Learn more about Types of Radiation Therapy.
  • Transarterial chemoembolization (TACE) and drug-eluting beads (DEB)
    Transarterial chemoembolization is a targeted form of chemotherapy delivered locally (sometimes through small beads) to destroy a tumor. TACE helps block blood supply to a tumor.
  • Transarterial radiotherapy
    Transarterial radiotherapy is the use of radioactive isotopes (Yttrium 90) delivered selectively to the tumor through the hepatic artery.
  • Chemotherapy and targeted therapy for hepatocellular carcinoma (HCC)
    Chemotherapy uses chemical agents to treat the disease.

Also see:

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: